A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors
Completed · Phase 2
Conditions studied: Haemostasis, Haemophilia A
In brief
This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to assess the efficacy of concizumab administered s.c. (subcutaneously, under the skin) once daily in preventing bleeding episodes in patients with severe haemophilia A without inhibitors.
Key facts
- Study ID
- NCT03196297
- Run by
- Novo Nordisk A/S
- People needed
- 36
- Starts
- 2017-08-16
- Expected to finish
- 2020-06-03
- Last updated by the study team
- 2021-11-16
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Novo Nordisk Investigational Site — Los Angeles, California, United States
- Novo Nordisk Investigational Site — Indianapolis, Indiana, United States
- Novo Nordisk Investigational Site — Oklahoma City, Oklahoma, United States
- Novo Nordisk Investigational Site — Nashville, Tennessee, United States
- Novo Nordisk Investigational Site — Salt Lake City, Utah, United States
- Novo Nordisk Investigational Site — Brest, France
- Novo Nordisk Investigational Site — Caen, France
- Novo Nordisk Investigational Site — Nantes, France
- Novo Nordisk Investigational Site — Bonn, Germany
- Novo Nordisk Investigational Site — Homburg, Germany
- Novo Nordisk Investigational Site — Milan, Italy
- Novo Nordisk Investigational Site — Rome, Italy
- Novo Nordisk Investigational Site — Aichi, Japan
- Novo Nordisk Investigational Site — Nara, Japan
- Novo Nordisk Investigational Site — Tokyo, Japan
- Novo Nordisk Investigational Site — Tokyo, Japan
- Novo Nordisk Investigational Site — Madrid, Spain
- Novo Nordisk Investigational Site — Málaga, Spain
- Novo Nordisk Investigational Site — Valencia, Spain
- Novo Nordisk Investigational Site — Malmö, Sweden
- Novo Nordisk Investigational Site — Solna, Sweden
- Novo Nordisk Investigational Site — Bangkok, Thailand
- Novo Nordisk Investigational Site — Ankara, Turkey (Türkiye)
- Novo Nordisk Investigational Site — Bornova-IZMIR, Turkey (Türkiye)
- Novo Nordisk Investigational Site — Edirne, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.